Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Similar articles for PubMed (Select 17896306)

1.

Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches.

Rein DB, Wirth KE, Johnson CA, Lee PP.

Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):258-64.

PMID:
17896306
2.

Quality-adjusted life years lost to road crash injury: updating the injury impairment index.

Spicer RS, Miller TR, Hendrie D, Blincoe LJ.

Ann Adv Automot Med. 2011;55:365-77.

3.

Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.

Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Lane SS.

Ophthalmology. 2011 Sep;118(9):1834-43. doi: 10.1016/j.ophtha.2011.02.012. Epub 2011 Jul 2.

PMID:
21723614
4.

Multi scale modal decomposition of primary form, waviness and roughness of surfaces.

Goic GL, Favrelière H, Samper S, Formosa F.

Scanning. 2011 Sep-Oct;33(5):332-41. doi: 10.1002/sca.20253. Epub 2011 Jun 21.

PMID:
21695704
5.

Cost-effectiveness of cataract surgery in Japan.

Hiratsuka Y, Yamada M, Murakami A, Okada AA, Yamashita H, Ohashi Y, Yamagishi N, Tamura H, Fukuhara S, Takura T; Eye Care Comparative Effectiveness Research Team (ECCERT).

Jpn J Ophthalmol. 2011 Jul;55(4):333-42. doi: 10.1007/s10384-011-0041-3. Epub 2011 Jun 22.

PMID:
21695383
6.

Single Cases Promote Knowledge Transfer in the Field of DBS.

Christen M, Müller S.

Front Integr Neurosci. 2011 May 5;5:13. doi: 10.3389/fnint.2011.00013. eCollection 2011. No abstract available.

7.

Cost-effectiveness of transforaminal lumbar interbody fusion for Grade I degenerative spondylolisthesis.

Adogwa O, Parker SL, Davis BJ, Aaronson O, Devin C, Cheng JS, McGirt MJ.

J Neurosurg Spine. 2011 Aug;15(2):138-43. doi: 10.3171/2011.3.SPINE10562. Epub 2011 May 6. Erratum in: J Neurosurg Spine. 2011 Aug;15(2):211.

PMID:
21529203
8.

Patient preferences for diabetic retinopathy health States.

Szabo SM, Beusterien KM, Pleil AM, Wirostko B, Potter MJ, Tildesley H, Gonder J, Barsdorf A, Levy AR.

Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3387-94. doi: 10.1167/iovs.09-4194. Epub 2010 Jan 6.

PMID:
20053977
9.

Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluations.

Grieve R, Guerriero C, Walker J, Tomlin K, Langham J, Harding S, Chakravathy U, Carpenter J, Reeves BC; Verteporfin Photodynamic Therapy Cohort Study Group.

Ophthalmology. 2009 Dec;116(12):2471-77.e1-2. doi: 10.1016/j.ophtha.2009.10.023.

PMID:
19948278
10.

Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.

Lieu TA, Ray GT, Ortega-Sanchez IR, Kleinman K, Rusinak D, Prosser LA.

Pharmacoeconomics. 2009;27(12):1005-16. doi: 10.2165/11314000-000000000-00000.

PMID:
19908925
11.

Natural history of open-angle glaucoma.

Heijl A, Bengtsson B, Hyman L, Leske MC; Early Manifest Glaucoma Trial Group.

Ophthalmology. 2009 Dec;116(12):2271-6. doi: 10.1016/j.ophtha.2009.06.042. Epub 2009 Oct 24.

PMID:
19854514
12.

Economic appraisal of the Boston Ocular Surface Prosthesis.

Shepard DS, Razavi M, Stason WB, Jacobs DS, Suaya JA, Cohen M, Rosenthal P.

Am J Ophthalmol. 2009 Dec;148(6):860-8.e2. doi: 10.1016/j.ajo.2009.07.012. Epub 2009 Sep 24.

PMID:
19781684
13.

Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration.

Hernández-Pastor LJ, Ortega A, García-Layana A, Giráldez J.

Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):467-76. doi: 10.1007/s00417-009-1156-9. Epub 2009 Aug 11.

PMID:
19669678
14.

The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.

Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB.

Ophthalmology. 2009 May;116(5):823-32. doi: 10.1016/j.ophtha.2008.12.056. Epub 2009 Mar 14.

PMID:
19285730
15.

Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.

Hernandez-Pastor LJ, Ortega A, Garcia-Layana A, Giraldez J.

Clin Ther. 2008 Dec;30(12):2436-51. doi: 10.1016/j.clinthera.2008.12.025.

PMID:
19167602
16.

Computerized model of cost-utility analysis for treatment of age-related macular degeneration.

Fletcher EC, Lade RJ, Adewoyin T, Chong NV.

Ophthalmology. 2008 Dec;115(12):2192-8. doi: 10.1016/j.ophtha.2008.07.018. Epub 2008 Oct 18.

PMID:
18930556
17.

The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.

Roe RH, Lass JH, Brown GC, Brown MM.

Cornea. 2008 Oct;27(9):1001-7. doi: 10.1097/ICO.0b013e31817bb062.

PMID:
18812762
18.

Vision impairment, ocular conditions, and vision-specific function: the Singapore Malay Eye Study.

Lamoureux EL, Chong EW, Thumboo J, Wee HL, Wang JJ, Saw SM, Aung T, Wong TY.

Ophthalmology. 2008 Nov;115(11):1973-81. doi: 10.1016/j.ophtha.2008.05.005. Epub 2008 Jun 26.

PMID:
18584873
19.

Vision-related quality of life in patients with pituitary adenoma.

Okamoto Y, Okamoto F, Hiraoka T, Yamada S, Oshika T.

Am J Ophthalmol. 2008 Aug;146(2):318-322. doi: 10.1016/j.ajo.2008.04.018. Epub 2008 Jun 6.

PMID:
18538298
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk